Endothelial cell regulation by phospholipid oxidation products

Free Radical Biology and Medicine

Volumn 45, Issue 2, 2008, Pages 119-123

  Berliner, Judith A ^a   Gharavi, Nima M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Kodia PC; Ox PAPC; Oxidized phospholipids; PEIPC; POVPC; Signaling

Indexed keywords

CELL SURFACE RECEPTOR; CHEMOKINE; CYTOKINE; LIPOPROTEIN; PHOSPHOLIPID; PROCOAGULANT;

ANGIOGENESIS; APOPTOSIS; ATHEROSCLEROSIS; CELL JUNCTION; CELL SURFACE; ENDOTHELIUM CELL; GENETIC TRANSCRIPTION; HUMAN; INFLAMMATION; LEUKOCYTE; LIPID OXIDATION; MONOCYTE; NECROSIS; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; OXIDATION-REDUCTION; PHOSPHOLIPIDS; SIGNAL TRANSDUCTION;

EID: 44649113051     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2008.04.013     Document Type: Review

References (50)

1. Watson A.D., Leitinger N., Navab M., Faull K.F., Horkko S., Witztum J.L., Palinski W., Schwenke D., Salomon R.G., Sha W., Subbanagounder G., Fogelman A.M., and Berliner J.A. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. J. Biol. Chem. 272 (1997) 13597-13607
2. Drake T.A., Hannani K., Fei H.H., Lavi S., and Berliner J.A. Minimally oxidized low-density lipoprotein induces tissue factor expression in cultured human endothelial cells. Am. J. Pathol. 138 (1991) 601-607
3. Leitinger N., Tyner T.R., Oslund L., Rizza C., Subbanagounder G., Lee H., Shih P.T., Mackman N., Tigyi G., Territo M.C., Berliner J.A., and Vora D.K. Structurally similar oxidized phospholipids differentially regulate endothelial binding of monocytes and neutrophils. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 12010-12015
4. Shih P.T., Elices M.J., Fang Z.T., Ugarova T.P., Strahl D., Territo M.C., Frank J.S., Kovach N.L., Cabanas C., Berliner J.A., and Vora D.K. Minimally modified low-density lipoprotein induces monocyte adhesion to endothelial connecting segment-1 by activating beta1 integrin. J. Clin. Invest. 103 (1999) 613-625
5. Marathe G.K., Prescott S.M., Zimmerman G.A., and McIntyre T.M. Oxidized LDL contains inflammatory PAF-like phospholipids. Trends Cardiovasc. Med. 11 (2001) 139-142
6. Berliner J.A., Subbanagounder G., Leitinger N., Watson A.D., and Vora D. Evidence for a role of phospholipid oxidation products in atherogenesis. Trends Cardiovasc. Med. 11 (2001) 142-147
7. Walton K.A., Cole A.L., Yeh M., Subbanagounder G., Krutzik S.R., Modlin R.L., Lucas R.M., Nakai J., Smart E.J., Vora D.K., and Berliner J.A. Specific phospholipid oxidation products inhibit ligand activation of toll-like receptors 4 and 2. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 1197-1203
8. Subbanagounder G., Deng Y., Borromeo C., Dooley A.N., Berliner J.A., and Salomon R.G. Hydroxy alkenal phospholipids regulate inflammatory functions of endothelial cells. Vascul. Pharmacol. 38 (2002) 201-209
9. Huber J., Vales A., Mitulovic G., Blumer M., Schmid R., Witztum J.L., Binder B.R., and Leitinger N. Oxidized membrane vesicles and blebs from apoptotic cells contain biologically active oxidized phospholipids that induce monocyte-endothelial interactions. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 101-107
10. Subbanagounder G., Wong J.W., Lee H., Faull K.F., Miller E., Witztum J.L., and Berliner J.A. Epoxyisoprostane and epoxycyclopentenone phospholipids regulate monocyte chemotactic protein-1 and interleukin-8 synthesis. Formation of these oxidized phospholipids in response to interleukin-1beta. J. Biol. Chem. 277 (2002) 7271-7281
11. Kiechl S., Willeit J., Mayr M., Viehweider B., Oberhollenzer M., Kronenberg F., Wiedermann C.J., Oberthaler S., Xu Q., Witztum J.L., and Tsimikas S. Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 1788-1795
12. Gargalovic P.S., Imura M., Zhang B., Gharavi N.M., Clark M.J., Pagnon J., Yang W.P., He A., Truong A., Patel S., Nelson S.F., Horvath S., Berliner J.A., Kirchgessner T.G., and Lusis A.J. Identification of inflammatory gene modules based on variations of human endothelial cell responses to oxidized lipids. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 12741-12746
13. Furnkranz A., Schober A., Bochkov V.N., Bashtrykov P., Kronke G., Kadl A., Binder B.R., Weber C., and Leitinger N. Oxidized phospholipids trigger atherogenic inflammation in murine arteries. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 633-638
14. Birukov K.G., Bochkov V.N., Birukova A.A., Kawkitinarong K., Rios A., Leitner A., Verin A.D., Bokoch G.M., Leitinger N., and Garcia J.G. Epoxycyclopentenone-containing oxidized phospholipids restore endothelial barrier function via Cdc42 and Rac. Circ. Res. 95 (2004) 892-901
15. Bochkov V.N. Inflammatory profile of oxidized phospholipids. Thromb. Haemost. 97 (2007) 348-354
16. Li R., Chen W., Yanes R., Lee S., and Berliner J.A. OKL38 is an oxidative stress response gene stimulated by oxidized phospholipids. J. Lipid Res. 48 (2007) 709-715
17. Gleissner C.A., Leitinger N., and Ley K. Effects of native and modified low-density lipoproteins on monocyte recruitment in atherosclerosis. Hypertension 50 (2007) 276-283
18. Cole A.L., Subbanagounder G., Mukhopadhyay S., Berliner J.A., and Vora D.K. Oxidized phospholipid-induced endothelial cell/monocyte interaction is mediated by a cAMP-dependent R-Ras/PI3-kinase pathway. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 1384-1390
19. Huo Y., Hafezi-Moghadam A., and Ley K. Role of vascular cell adhesion molecule-1 and fibronectin connecting segment-1 in monocyte rolling and adhesion on early atherosclerotic lesions. Circ. Res. 87 (2000) 153-159
20. Shih P.T., Brennan M.L., Vora D.K., Territo M.C., Strahl D., Elices M.J., Lusis A.J., and Berliner J.A. Blocking very late antigen-4 integrin decreases leukocyte entry and fatty streak formation in mice fed an atherogenic diet. Circ. Res. 84 (1999) 345-351
21. Li R., Mouillesseaux K.P., Montoya D., Cruz D., Gharavi N., Dun M., Koroniak L., and Berliner J.A. Identification of prostaglandin E2 receptor subtype 2 as a receptor activated by OxPAPC. Circ. Res. 98 (2006) 642-650
22. Vora D.K., Fang Z.T., Liva S.M., Tyner T.R., Parhami F., Watson A.D., Drake T.A., Territo M.C., and Berliner J.A. Induction of P-selectin by oxidized lipoproteins. Separate effects on synthesis and surface expression. Circ. Res. 80 (1997) 810-818
23. Dong Z.M., Chapman S.M., Brown A.A., Frenette P.S., Hynes R.O., and Wagner D.D. The combined role of P-and E-selectins in atherosclerosis. J. Clin. Invest. 102 (1998) 145-152
24. Honda H.M., Leitinger N., Frankel M., Goldhaber J.I., Natarajan R., Nadler J.L., Weiss J.N., and Berliner J.A. Induction of monocyte binding to endothelial cells by MM-LDL: role of lipoxygenase metabolites. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 680-686
25. Patricia M.K., Kim J.A., Harper C.M., Shih P.T., Berliner J.A., Natarajan R., Nadler J.L., and Hedrick C.C. Lipoxygenase products increase monocyte adhesiontohuman aortic endothelial cells. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 2615-2622
26. Yeh M., Leitinger N., de Martin R., Onai N., Matsushima K., Vora D.K., Berliner J.A., and Reddy S.T. Increased transcription of IL-8 in endothelial cells is differentially regulated by TNF-alpha and oxidized phospholipids. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 1585-1591
27. Gharavi N.M., Alva J.A., Mouillesseaux K.P., Lai C., Yeh M., Yeung W., Johnson J., Szeto W.L., Hong L., Fishbein M., Wei L., Pfeffer L.M., and Berliner J.A. Role of the Jak/STAT pathway in the regulation of interleukin-8 transcription by oxidized phospholipids in vitro and in atherosclerosis in vivo. J. Biol. Chem. 282 (2007) 31460-31468
28. Gharavi N.M., Baker N.A., Mouillesseaux K.P., Yeung W., Honda H.M., Hsieh X., Yeh M., Smart E.J., and Berliner J.A. Role of endothelial nitric oxide synthase in the regulation of SREBP activation by oxidized phospholipids. Circ. Res. 98 (2006) 768-776
29. Yeh M., Cole A.L., Choi J., Liu Y., Tulchinsky D., Qiao J.H., Fishbein M.C., Dooley A.N., Hovnanian T., Mouilleseaux K., Vora D.K., Yang W.P., Gargalovic P., Kirchgessner T., Shyy J.Y., and Berliner J.A. Role for sterol regulatory element-binding protein in activation of endothelial cells by phospholipid oxidation products. Circ. Res. 95 (2004) 780-788
30. Zimman A., Mouillesseaux K.P., Le T., Gharavi N.M., Ryvkin A., Graeber T.G., Chen T.T., Watson A.D., and Berliner J.A. Vascular endothelial growth factor receptor 2 plays a role in the activation of aortic endothelial cells by oxidized phospholipids. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 332-338
31. Jin Z.G., Ueba H., Tanimoto T., Lungu A.O., Frame M.D., and Berk B.C. Ligand-independent activation of vascular endothelial growth factor receptor 2 by fluid shear stress regulates activation of endothelial nitric oxide synthase. Circ. Res. 93 (2003) 354-363
32. Gargalovic P.S., Gharavi N.M., Clark M.J., Pagnon J., Yang W.P., He A., Truong A., Baruch-Oren T., Berliner J.A., Kirchgessner T.G., and Lusis A.J. The unfolded protein response is an important regulator of inflammatory genes in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 2490-2496
33. Lee H., Shi W., Tontonoz P., Wang S., Subbanagounder G., Hedrick C.C., Hama S., Borromeo C., Evans R.M., Berliner J.A., and Nagy L. Role for peroxisome proliferator-activated receptor alpha in oxidized phospholipid-induced synthesis of monocyte chemotactic protein-1 and interleukin-8 by endothelial cells. Circ. Res. 87 (2000) 516-521
34. Walton K.A., Hsieh X., Gharavi N., Wang S., Wang G., Yeh M., Cole A.L., and Berliner J.A. Receptors involved in the oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine-mediated synthesis of interleukin-8. A role for Toll-like receptor 4 and a glycosylphosphatidylinositol-anchored protein. J. Biol. Chem. 278 (2003) 29661-29666
35. Miller Y.I., Viriyakosol S., Worrall D.S., Boullier A., Butler S., and Witztum J.L. Toll-like receptor 4-dependent and-independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 1213-1219
36. Bochkov V.N., Kadl A., Huber J., Gruber F., Binder B.R., and Leitinger N. Protective role of phospholipid oxidation products in endotoxin-induced tissue damage. Nature 419 (2002) 77-81
37. Walton K.A., Gugiu B.G., Thomas M., Basseri R.J., Eliav D.R., Salomon R.G., and Berliner J.A. A role for neutral sphingomyelinase activation in the inhibition of LPS action by phospholipid oxidation products. J. Lipid Res. 47 (2006) 1967-1974
38. Gong K.W., Zhao W., Li N., Barajas B., Kleinman M., Sioutas C., Horvath S., Lusis A.J., Nel A., and Araujo J.A. Air-pollutant chemicals and oxidized lipids exhibit genome-wide synergistic effects on endothelial cells. Genome Biol. 8 (2007) R149
39. Bochkov V.N., Mechtcheriakova D., Lucerna M., Huber J., Malli R., Graier W.F., Hofer E., Binder B.R., and Leitinger N. Oxidized phospholipids stimulate tissue factor expression in human endothelial cells via activation of ERK/EGR-1 and Ca(+)/NFAT. Blood 99 (2002) 199-206
40. Chang P.Y., Luo S., Jiang T., Lee Y.T., Lu S.C., Henry P.D., and Chen C.H. Oxidized low-density lipoprotein downregulates endothelial basic fibroblast growth factor through a pertussis toxin-sensitive G-protein pathway: mediator role of platelet-activating factor-like phospholipids. Circulation 104 (2001) 588-593
41. Ishii H., Tezuka T., Ishikawa H., Takada K., Oida K., and Horie S. Oxidized phospholipids in oxidized low-density lipoprotein down-regulate thrombomodulin transcription in vascular endothelial cells through a decrease in the binding of RARbeta-RXRalpha heterodimers and Sp1 and Sp3 to their binding sequences in the TM promoter. Blood 101 (2003) 4765-4774
42. Ohkura N., Hiraishi S., Itabe H., Hamuro T., Kamikubo Y., Takano T., Matsuda J., and Horie S. Oxidized phospholipids in oxidized low-density lipoprotein reduce the activity of tissue factor pathway inhibitor through association with its carboxy-terminal region. Antioxid. Redox. Signal. 6 (2004) 705-712
43. Birukova A.A., Chatchavalvanich S., Oskolkova O., Bochkov V.N., and Birukov K.G. Signaling pathways involved in OxPAPC-induced pulmonary endothelial barrier protection. Microvasc. Res. 73 (2007) 173-181
44. Birukova A.A., Malyukova I., Mikaelyan A., Fu P., and Birukov K.G. Tiam1 and betaPIX mediate Rac-dependent endothelial barrier protective response to oxidized phospholipids. J. Cell. Physiol. 211 (2007) 608-617
45. Rouhanizadeh M., Hwang J., Clempus R.E., Marcu L., Lassegue B., Sevanian A., and Hsiai T.K. Oxidized-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine induces vascular endothelial superoxide production: implication of NADPH oxidase. Free Radic. Biol. Med. 39 (2005) 1512-1522
46. Therond P., Abella A., Laurent D., Couturier M., Chalas J., Legrand A., and Lindenbaum A. In vitro study of the cytotoxicity of isolated oxidized lipid low-density lipoproteins fractions in human endothelial cells: relationship with the glutathione status and cell morphology. Free Radic. Biol. Med. 28 (2000) 585-596
47. Landar A., Zmijewski J.W., Dickinson D.A., Le Goffe C., Johnson M.S., Milne G.L., Zanoni G., Vidari G., Morrow J.D., and Darley-Usmar V.M. Interaction of electrophilic lipid oxidation products with mitochondria in endothelial cells and formation of reactive oxygen species. Am. J. Physiol., Heart Circ. Physiol. 290 (2006) H1777-H1787
48. Kronke G., Bochkov V.N., Huber J., Gruber F., Bluml S., Furnkranz A., Kadl A., Binder B.R., and Leitinger N. Oxidized phospholipids induce expression of human heme oxygenase-1 involving activation of cAMP-responsive element-binding protein. J. Biol. Chem. 278 (2003) 51006-51014
49. Gugiu B.G., Mouillesseaux K., Duong V., Herzog T., Hekimian A., Koroniak L., Vondriska T.M., and Watson A.D. Protein targets of oxidized phospholipids in endothelial cells. J. Lipid Res. 49 (2008) 510-520
50. Salomon R.G. Isolevuglandins, oxidatively truncated phospholipids, and atherosclerosis. Ann. N.Y. Acad. Sci. 1043 (2005) 327-342